Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
ISELIN, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United...
Webcast replay of fireside chat now available ISELIN, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory...
Topline results from NORSE EIGHT expected in Q4 CY2024 ISELIN, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved...
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United...
Received European Union (EU) and United Kingdom (UK) Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMDNORSE EIGHT current enrollment pace supports topline...
ISELIN, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on development and commercialization of ONS-5010/LYTENAVA™...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.07 | -15.2204836415 | 7.03 | 7.26 | 5.8805 | 369240 | 6.19675013 | CS |
4 | -1.34 | -18.3561643836 | 7.3 | 8.32 | 5.8805 | 237092 | 6.90129872 | CS |
12 | -1.19 | -16.6433566434 | 7.15 | 9.25 | 5.8805 | 202494 | 7.48113108 | CS |
26 | -1.63 | -21.4756258235 | 7.59 | 12.8499 | 5.8805 | 441918 | 8.38672937 | CS |
52 | 1.7 | 39.9061032864 | 4.26 | 18 | 4.092 | 2573166 | 9.1776515 | CS |
156 | -40.24 | -87.0995670996 | 46.2 | 48 | 4.004 | 1859700 | 15.37467023 | CS |
260 | -26.64 | -81.717791411 | 32.6 | 85.2 | 4.004 | 1889113 | 23.53551854 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.